Saeed Shanehsazzadeh | Agricultural and Biological Sciences | Best Scholar Award

Published on by Phenomenological Research Awards

Dr. Saeed Shanehsazzadeh | Agricultural and Biological Sciences | Best Scholar Award

Postdoc at University of New South Wales | Australia

Dr. Saeed Shanehsazzadeh is an accomplished medical physicist with over a decade of international research experience spanning Australia, Singapore, Canada, Belgium, and Iran. He is recognized for his expertise in molecular imaging, radiopharmaceutical development, and nanotechnology. With 55 publications and over 1,564 citations, his scientific influence is evident, reinforced by an H-index of 26. His work centers on imaging modalities like PET, SPECT, MRI, and MPI, developing contrast agents and multimodal probes. Dr. Shanehsazzadeh has received multiple competitive grants and 10 international awards. He is currently a fellow at UNSW and Western Sydney University, driving innovation in Alzheimer’s disease imaging.

Profile:

 Orcid | Google Scholar

Education:

Dr. Saeed Shanehsazzadeh earned his PhD in Medical Physics from Tehran University of Medical Sciences in 2013, focusing on nanoparticle-based imaging of breast cancer. He holds a Master’s in Medical Physics from Isfahan University (2008), where he investigated radiolabeled GnRH agonists for tumor detection, and a Bachelor’s in Applied Physics from Yazd University (2003). His academic foundation combines theoretical and applied physics, particularly radiological sciences and nanomedicine. Over the years, he has augmented his qualifications with certifications in project management, machine learning, clinical trials, and medical physics training from renowned institutions such as UCLA, Duke University, and ICTP Italy.

Experience:

Dr. Saeed Shanehsazzadeh’s research trajectory includes fellowships at prestigious institutions such as UNSW, University of Western Sydney, and the National University of Singapore. His contributions include developing Alzheimer’s disease nanoprobes, managing imaging labs, and mentoring graduate students. He previously worked as a senior research fellow, lab manager, and assistant professor, managing multidisciplinary projects involving PET, SPECT, and MRI. His postdoctoral appointments in Canada and Belgium furthered his expertise in radiomics and dual-modality contrast agents. He has conducted extensive animal imaging studies, designed SOPs, analyzed quantitative data with Python and MATLAB, and contributed to regulatory and ethical frameworks for biomedical research.

Research Interest:

Dr. Saeed Shanehsazzadeh’s research focuses on molecular imaging, nanomedicine, contrast agent development, and neuroimaging, particularly in Alzheimer’s disease. His interdisciplinary approach integrates physics, chemistry, and biomedical engineering. He is actively investigating dual-modality probes for PET/MRI, MPI tracers, and nanoparticle-based drug delivery systems for brain-targeted therapy. His recent work addresses neuroinflammation, signal detection in multimodal imaging, and the optimization of nanoparticles for theranostics. He is also interested in radiopharmaceutical dosimetry, radiomics, and the application of machine learning in image analysis. His goal is to enhance diagnostic precision and personalized treatment strategies through innovative imaging technologies.

Award and Honors:

Dr. Saeed Shanehsazzadeh has been honored with 10 international awards, reflecting his excellence in research and presentation. Highlights include the Best Poster Award at the 8th ASMI Symposium (Sydney, 2023), Outstanding Lecture Award at the International Isotopes Conference (Seoul, 2008), and Best Poster Award at ACRR (2009). He also received awards from IAEA and ICTP for his work on Ga-68 imaging agents and was recognized as the Best Researcher Student at Tehran University. His grants and recognitions span over a dozen competitive travel and research support awards from Australia, Korea, Germany, and Italy, validating the global impact of his work.

Publications:

Title: Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer

Citations: 170

Year of Publication: 2016

Title: Monoclonal antibody conjugated magnetic nanoparticles could target MUC‐1‐positive cells in vitro but not in vivo

Citations: 72

Year of Publications: 2015

Title: Graphene/Cobalt Nanocarrier for Hyperthermia Therapy and MRI Diagnosis

Citations: 71

Year of Publications: 2016

Title: Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process

Citations: 65

Year of Publications: 2016

Title: Dual nano‐sized contrast agents in PET/MRI: a systematic review

Citations: 54

Year of Publications: 2016

Title: Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice

Citations: 53

Year of Publications: 2013

Conclusion:

Dr. Saeed Shanehsazzadeh stands out as a global leader in medical physics and nanotechnology-driven imaging research. His interdisciplinary projects span the most cutting-edge imaging techniques and are backed by strong publication metrics and prestigious awards. His career is marked by sustained innovation, effective collaboration, and mentorship. With continuous funding and institutional trust, his work is shaping the future of personalized medicine and diagnostic radiology. This nomination affirms his enduring impact on molecular imaging and his suitability for recognition as a top researcher in the biomedical imaging domain.

Hermann L. Müller | Medicine and Dentistry | Women Researcher Award

Published on by Phenomenological Research Awards

Prof. Dr. Hermann L Muller | Medicine and Dentistry | Women Researcher Award

M.D at Klinikum Oldenburg AöR Medical Campus University Oldenburg | Germany

Prof. Dr. Hermann L. Müller is a distinguished pediatrician and academic leader based in Germany. He currently serves as Professor of Pediatrics and Head of the Department of Pediatrics and Pediatric Hematology and Oncology at Klinikum Oldenburg, part of the European Medical School Oldenburg-Groningen. With a career dedicated to advancing pediatric care, Dr. Müller has made significant strides in pediatric oncology and endocrinology, particularly in the study of childhood craniopharyngioma. His collaborative efforts in multinational clinical trials and leadership roles in international societies reflect his commitment to improving treatment outcomes and quality of life for pediatric patients globally.

Profile:

 Orcid

Education:

Prof. Dr. Hermann L. Müller began his medical training in general pediatrics at the University of Marburg and the University of Würzburg, Germany. He further honed his clinical and research expertise through a prestigious post-doctoral fellowship at Stanford University Medical Center under Prof. Dr. Ron Rosenfeld from 1991 to 1993. Following his time in the U.S., he specialized in pediatric oncology, hematology, endocrinology, and diabetology at the Department of Pediatrics, University of Würzburg. His educational trajectory reflects a deep interdisciplinary foundation that has propelled his pioneering work in pediatric neuro-oncology and endocrinology.

Experience:

With decades of clinical and academic experience, Prof. Dr. Hermann L. Müller has served as a leading figure in pediatric medicine. Since 1999, he has been coordinating major clinical trials, including the German/European craniopharyngioma trials HIT-ENDO and KRANIOPHARYNGEOM 2000/2007, involving over 590 patients across Germany, Austria, and Switzerland. Between 2004 and 2011, he was the speaker for the Craniopharyngioma Subgroup of the International Society of Paediatric Oncology (SIOP). At Klinikum Oldenburg, he leads a team dedicated to pediatric hematology, oncology, and endocrinology, integrating clinical excellence with teaching at the Carl von Ossietzky University of Oldenburg.

Research Interest:

Prof. Dr. Hermann L. Müller’s research is centered on the late effects of pediatric oncological diseases, neuro-endocrinology, and hypothalamic disorders. He has a special focus on craniopharyngioma—a rare brain tumor affecting children—and the associated complications such as hypothalamic obesity and disrupted satiety regulation. His work explores both diagnostic methodologies and therapeutic interventions for these conditions, emphasizing long-term patient outcomes and quality of life. Through clinical trials and translational research, he has significantly advanced the understanding of hypothalamic dysfunction and the neuroendocrine sequelae of childhood brain tumors.

Awards and Honors:

Prof. Dr. Hermann L. Müller’s contributions to pediatric oncology and endocrinology have earned him significant recognition within the scientific community. While specific awards are not detailed in the provided CV, his longstanding leadership in European and international clinical trials, coupled with his role in academic pediatric medicine, underscores his stature as a leading expert. His coordination of landmark studies, such as HIT-ENDO, and representation in global professional societies further attest to his impact. His nomination for an award acknowledges both his scientific rigor and his commitment to improving care for children with complex neuro-oncological conditions.

Publications Top Notes:

Title: Childhood craniopharyngioma: treatment strategies and outcomes

Citations: 498

Year of Publication: 2014

Title: Craniopharyngioma and hypothalamic injury: Latest insights into consequent eating disorders and obesity

Citations: 120

Year of Publication: 2016

Title: Management of Hypothalamic Obesity

Citations: 45

Year of Publication: 2020

Title: Craniopharyngioma a chronic disease

Citations: 11

Year of Publication: 2018

Title: Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome

Citations: 53

Year of Publication: 2016

Title: A systematic review of cognitive performance in patients with childhood craniopharyngioma

Citations: 66

Year of Publication: 2015

Conclusion:

Prof. Dr. Hermann L. Müller stands as a global authority in pediatric oncology and neuro-endocrinology, with a career marked by innovation, leadership, and compassion. His extensive clinical experience, coupled with an exceptional research portfolio and educational contributions, reflects a lifelong dedication to improving pediatric healthcare. His pioneering studies on craniopharyngioma and hypothalamic disorders have transformed treatment approaches and informed international guidelines. Recognizing his achievements through this award would honor a professional who has profoundly impacted children’s lives and fostered meaningful international collaborations in pediatric medicine.

Hsin Yuan Chen | Engineering | Best Scholar Award

Published on by Phenomenological Research Awards

Prof. Hsin Yuan Chen | Engineering | Best Scholar Award

Professor at Zhejiang University | China

Dr. Hsin Yuan Chen is a leading scholar and technologist, currently serving as a Changjiang Scholar Professor and Director at Zhejiang University’s Institute of Wenzhou, Center of Digital Technology Entrepreneurship and Innovation. With an extensive academic and industrial background, she has made significant contributions in smart agriculture, AI, robotics, and digital transformation. Dr. Chen’s interdisciplinary expertise bridges engineering, healthcare, and artificial intelligence, and her work has impacted education, industry collaboration, and technological advancement across Asia. Her recognition includes international fellowships, keynote speaker roles, and leadership in major research centers, positioning her as a dynamic force in intelligent systems and innovation.

Profile:

Google Scholar

Education:

Dr. Hsin Yuan Chen earned her Bachelor’s and Ph.D. degrees in Aerospace Engineering from National Cheng Kung University, Taiwan, completing her doctorate in 2000. She complemented her formal education with a visiting professorship at Washington University in St. Louis, USA, which deepened her global academic perspective. Her educational journey has been distinguished by a strong foundation in systems control, aerospace, and robotics, which later evolved to encompass AI, digital agriculture, and interdisciplinary technology management. This robust academic training underpins her approach to integrating theoretical insights with practical innovations in smart technologies and data-driven platforms.

Experience:

Dr. Hsin Yuan Chen’s professional journey spans over two decades of academic, governmental, and industrial roles. She served as Professor and Dean at Fujian Normal University, CTO at GEOSAT Technology and Mobiletron Electronics, and Assistant Professor at multiple Taiwanese institutions. Additionally, she held advisory roles in patent offices and high-tech companies, contributing to projects on AI positioning systems, smart agriculture, and unmanned vehicles. Her international engagements include collaborations with institutions such as McGill University and Washington University. These diverse experiences enrich her ability to lead transdisciplinary teams and execute complex, innovation-focused initiatives across multiple sectors.

Research Interest:

Dr. Hsin Yuan Chen’s research focuses on the convergence of artificial intelligence, smart agriculture, IoT, blockchain, and autonomous systems. Her projects have addressed real-world challenges in digital transformation, healthcare innovation, and sustainable agriculture. A particular interest lies in integrating explainable AI with blockchain to enhance decision-making in agricultural technology. She is also actively involved in robotics, wireless positioning systems, and medical platforms leveraging sensor technology. Her passion for developing inclusive, intelligent systems is reflected in her projects like AI Doctors for crops and Paro Robots for health monitoring, aiming to merge emotion detection with deep learning-based automation.

Awards and Honors:

Dr. Hsin Yuan Chen has received prestigious accolades including the ScienceFather International Outstanding Scientist Award (2024), IET Fellowship (2023), and ASEAN Fellowship (2022). She was recognized with national teaching excellence awards, innovation medals in higher education, and championship titles in robotics competitions. Her pioneering work has also earned distinctions in cloud technology and virtual cultural heritage. As a member of high-level talent programs in Zhejiang and Fujian Provinces, and a recipient of multiple creativity group medals, Dr. Chen’s impact extends across education, technology, and international science forums. Her awards reflect both scholarly excellence and societal contributions.

Publications:

Title: Exploring the sensitivity of next generation gravitational wave detectors

Citations: 1533

Year of Publication: 2017

Title: Cosmology intertwined: A review of the particle physics, astrophysics, and cosmology associated with the cosmological tensions and anomalies

Citations: 1322

Year of Publication: 2022

Title: Carbon nanotube computer

Citations: 1228

Year of Publication: 2013

Title: Three dimensional reconstruction of a solid-oxide fuel-cell anode

Citations: 1019

Year of Publication: 2006

Title: GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

Citations: 895

Year of Publication: 2008

Title: Plasmonic nanolaser using epitaxially grown silver film

Citations: 878

Year of Publication: 2012

Title: Translation and back‐translation in qualitative nursing research: methodological review

Citations: 874

Year of Publication: 2010

Conclusion:

Dr. Hsin Yuan Chen exemplifies excellence in research, leadership, and innovation, making her a strong candidate for the Best Researcher Award. Her prolific output in scientific publications, transformative projects in smart agriculture and digital health, and her commitment to knowledge transfer through academia-industry collaborations illustrate her deep impact. Dr. Chen’s fusion of AI with real-world applications—particularly in sustainable systems and intelligent automation—positions her at the forefront of global innovation. Her recognition across international platforms affirms her thought leadership and the lasting value of her contributions to science, technology, and education.

Jorge Zumaeta | Economics | Best Researcher Award

Published on by Phenomenological Research Awards

Dr. Jorge Zumaeta | Economics | Best Researcher Award 

Professor at Florida International University | United States 

Dr. Jorge Zumaeta is a distinguished scholar and senior academic administrator whose career spans over three decades in macroeconomics, labor economics, and socio-economic development. He serves as Senior Director at Florida International University and a Senior Research Affiliate at Duke University’s Samuel DuBois Cook Center on Social Equity. His work bridges academic research with community-focused economic policy, emphasizing equity, liberty, and workforce development. Known for his exceptional leadership, he has contributed to national policy through high-impact research, strategic planning, and cross-institutional collaborations. Dr. Jorge Zumaeta is committed to preparing future leaders with an ethical and economically informed worldview grounded in classical and modern principles.

Profile:

Orcid | Google Scholar

Education:

Dr. Jorge Zumaeta holds a Ph.D. in Social Science from Tilburg University in the Netherlands, an M.S. in Economics from Florida Atlantic University, and a B.A. in Economics from the same institution. His academic training combines rigorous theoretical foundations with applied economic methodologies, particularly in labor markets and macroeconomic stability. His doctoral work emphasized the intersection of economic equity and academic access. Throughout his academic path, Dr. Jorge Zumaeta has remained focused on empowering underrepresented communities through education and economic opportunity. His transatlantic education has shaped his global perspective and guided his commitment to equitable development through evidence-based research.

Experience:

With a career rooted in both public and academic sectors, Dr. Jorge Zumaeta has held leadership roles at Florida International University since 2007, managing academic planning, accreditation, and workforce alignment initiatives. He previously worked with Miami-Dade County as a Senior Economic and Policy Analyst, and earlier served as Associate Director at Florida Atlantic University’s employment training institute. His experience spans strategic policy development, econometric research, community redevelopment planning, and fiscal management. He has led national and international presentations, developed economic indicators, and collaborated with federal agencies. His practical insights have directly influenced labor policy, workforce strategies, and institutional effectiveness across various regions.

Research Interest:

Dr. Jorge Zumaeta’s research lies at the nexus of applied macroeconomics, labor market dynamics, and socio-economic equity. His recent studies explore disparities in income, wealth, and incarceration, particularly in minority communities. He utilizes advanced econometric tools to evaluate the impact of job training programs, academic policy interventions, and misinformation in the digital age. A significant portion of his work assesses the socioeconomic effects of institutional structures, aiming to offer policy solutions rooted in academic rigor and equity frameworks. His interdisciplinary focus blends economics, public policy and data science to produce insights that serve both scholarship and real-world transformation.

Awards and Honors:

Dr. Jorge Zumaeta’s contributions have earned him numerous accolades, including the Fulbright Research Chair (2016–17), FIU FLAME Award (2020, 2021), APEX Award (2020), and High Impact Leadership Award (2018). He was a Top Scholar at FIU in 2016 and received multiple community engagement recognitions, such as nominations for the SPOT and Community Awards. As a National Science Foundation DITE Fellow and Faculty Mentor, he has mentored emerging economists in diversity-driven research. His strategic involvement with county-level economic councils and chambers reflects his leadership in policy-making and commitment to advancing equitable development through multidisciplinary collaboration.

Publications Top Notes:

Title: Racial Disparities in Family Income, Assets, and Liabilities: A Century After the 1921 Tulsa Massacre
Citations: 3
Year of Publications: 2024

Title: The Incarceration Penalty and Black-White Economic Inequality: The Case of Baltimore
Citations: 1
Years of Publications: 2023

Title: Money Illusion in Charitable Giving in the Absence of Market Price Resistance
Citations: 1
Year of Publications: 2021

Title: A Logistic Regression Analysis to Assist Welfare Recipients Attaining Employment
Citations: 1
Year of Publications: 2021

Title: Meta-Analysis of Seven Standard Experimental Paradigms Comparing Student to Non-student
Citations: 1
Year of Publications: 2021

Conclusion:

Dr. Jorge Zumaeta exemplifies the values of a visionary researcher and public intellectual. His integration of academic inquiry with policy application positions him as a transformative leader in economics and public service. His contributions span publications, federal research initiatives, curriculum development, and community advocacy, making him a deserving nominee for the Best Researcher Award. His scholarly impact and unwavering dedication to social equity, economic development, and educational access embody the spirit of excellence and civic responsibility. Recognizing Dr. Zumaeta would honor a career dedicated to uplifting communities through evidence-based research and inclusive education.

Maria Rosa Gigliobianco | Nanotechnology and cosmetics research | Best Researcher Award

Published on by Phenomenological Research Awards

Prof. Maria Rosa Gigliobianco | Nanotechnology and cosmetics research | Best Researcher Award

RTD-A at University G. D’Annunzio of Chieti and Pescara|Italy

Dr.Maria Rosa Gigliobianco is a pharmaceutical scientist and researcher specializing in nanomedicine and drug delivery systems. Currently serving as a researcher (RTD-A) at the University of G. d’Annunzio, she is the Principal Investigator of a government-funded project on nanonetwork strategies for cancer treatment. Her work bridges pharmaceutical chemistry and biomedical innovation, focusing on novel biomaterials, hydrogels, and nanoparticle-based systems. With experience across European institutions and participation in prestigious fellowships like the Marie Skłodowska-Curie, Dr. Gigliobianco has become a recognized expert in drug delivery and formulation. Her dynamic career has impacted biomedical research and the development of targeted therapeutic systems.

Profile:

Orcid  | Google Scholar 

Education:

Dr.Maria Rosa Gigliobianco earned dual Master’s degrees in Pharmacy and Pharmaceutical Chemistry and Technology from the University of Camerino, where she also completed a Ph.D. in Chemical and Pharmaceutical Sciences and Biotechnologies. Her doctoral research involved synthesizing and characterizing targeted polymeric nanoparticles for biomedical applications, integrating techniques such as DLS, NMR, HPLC, FTIR, SEM, and in vitro studies. She holds a pharmacist license and has built a solid foundation in formulation science and nanoparticle engineering. Her academic training has provided her with a multidisciplinary edge that complements her postdoctoral research in cosmetic, pharmaceutical, and biomaterial-based drug delivery innovations.

Professional Experience:

Dr.Maria Rosa Gigliobianco’s professional journey spans academia and international research centers. She has held multiple postdoctoral positions at the University of Camerino and served as a senior scientist at Percuros BV in the Netherlands under the MSCA Individual Fellowship. Her career includes significant contributions to cancer nanotherapy, nose-to-brain delivery systems, and the formulation of natural biomaterials. Currently, she leads a nanonetwork cancer therapy project as PI. Dr. Gigliobianco has also been a visiting researcher at LUMC in Leiden and lectures as a subject expert in pharmaceutical technology. Her mentorship of over 30 master’s students and 10 Ph.D. researchers demonstrates her academic leadership.

Research Interests:

Her research centers on the design and development of innovative nano- and macro-delivery platforms for pharmaceutical and cosmetic applications. She focuses on polymeric nanoparticles, hydrogels, bioactive compounds, and nanocrystals aimed at overcoming bioavailability challenges, particularly in cancer and neurodegenerative conditions. Dr. Gigliobianco is deeply invested in using waste-derived biomaterials for sustainable formulations. She applies advanced analytical techniques for material characterization and emphasizes nose-to-brain delivery strategies. Her work contributes to the evolution of eco-friendly, patient-centric therapies and fosters interdisciplinary collaborations in biomaterials, biotechnology, and therapeutic formulation.

Awards and Honors:

Dr.Maria Rosa Gigliobianco has received several prestigious accolades. In 2021, she was awarded the MSCA Individual European Fellowship (H2020), a competitive grant for innovative European research. She earned “Best Poster Presentation” awards in 2015 and 2019, including from the CRS Italy Chapter. Her master’s thesis was honored with the “Donna e Scienza” Rita Levi Montalcini award. She also received competitive fellowships from the University of Camerino during her Master’s and Ph.D. studies. These recognitions reflect her scientific excellence and commitment to advancing pharmaceutical technology through innovative research and public dissemination of knowledge.

Publications:

Title: Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability
Citations: 305
Published Year: 2018

Title: Hot Melt Extrusion: Highlighting Physicochemical Factors to Be Investigated While Designing and Optimizing a Hot Melt Extrusion Process
Citations: 152
Published Year: 2018

Title: Nano-medicine improving the bioavailability of small molecules for the prevention of neurodegenerative diseases
Citations: 32
Published Year: 2017

Title: New nanometric solid dispersions of glibenclamide in Neusilin® UFL2
Citations: 19
Published Year: 2016

Title: Formation, physicochemical characterization, and thermodynamic stability of the amorphous state of drugs and excipients
Citations: 12
Published Year: 2016

Title: Effect of poly (vinylpyrrolidone) or sodium alginate on the stability of the amorphous form of nimesulide
Citations: 8
Published Year: 2016

Title: Effect of Grinding on the Solid-State Stability and Particle Dissolution of Acyclovir Polymorphs
Citations: 7
Published Year: 2017

Conclusion:

Dr.Maria Rosa Gigliobianco is a highly qualified nominee for a research award recognizing excellence in nanomedicine and pharmaceutical sciences. Her multidisciplinary expertise, sustained research productivity, and commitment to training future scientists make her a valuable contributor to scientific advancement. Her projects address urgent healthcare challenges with innovative, sustainable, and practical solutions. Recognized by European institutions and academia, she continues to lead impactful research in cancer therapy, neurodegenerative diseases, and eco-friendly formulation technologies. Her achievements exemplify the caliber and vision required for global scientific recognition in medicine and biopharmaceutical innovation.

Amanda Lee | Nursing and Health Professions | Best Researcher Award

Published on by Phenomenological Research Awards

Dr Amanda Lee | Nursing and Health Professions | Best Researcher Award

Snr Lecturer at Manchester Metropolitan University, United Kingdom.

Dr. Amanda Lee is a globally recognized academic leader, nurse practitioner, and health sciences researcher whose career spans over three decades and four continents. With qualifications in adult nursing, midwifery, and advanced clinical practice, she has made outstanding contributions to clinical care, higher education, health policy, and interdisciplinary research. Holding a PhD in Health Sciences with a specialization in cancer epidemiology, Dr. Lee has developed pioneering methodologies that integrate health and geospatial sciences to improve healthcare planning. She is known not only for her scholarly output but also for her leadership in shaping transnational education programs and advising governmental healthcare bodies in the UK, Australia, Singapore, and China.

Profile:

Education:

Dr. Lee’s academic journey reflects a profound commitment to lifelong learning. She holds a PhD in Health Sciences from the University of Hull, an MSc in Nurse Practitioner studies from Curtin University in Australia, a BSc Hons in Midwifery from Leeds University, and several postgraduate diplomas in education and advanced nursing practice. Her broad academic foundation across nursing, midwifery, education, and research methodology has empowered her to lead in both clinical and academic environments with confidence and authority.

💼 Professional Experience:

Dr. Amanda Lee is a seasoned healthcare academic and leader with over 30 years of diverse professional experience spanning clinical practice, higher education, research, and international consultancy. She has held senior roles such as Executive Dean, Associate Dean (International), and Senior Lecturer across institutions in the UK, Australia, and Asia. Her career highlights include leading transnational nursing programs, supervising PhD students, securing competitive research funding, and advising government health bodies on advanced practice, non-medical prescribing, and educational strategy. Clinically, she has served as a neonatal nurse, ward sister, and nurse practitioner, and academically, she has managed multidisciplinary teams and developed inclusive, evidence-informed curricula for global healthcare education.

🧪 Research Excellence:

With over 41 peer-reviewed publications, an h-index of 12, and more than 740 citations, Dr. Lee is a prolific contributor to the global body of knowledge in health sciences. Her research interests include cancer epidemiology, nursing education, health geographics, and community-based interventions. Notably, her PhD work developed an innovative population health model using geographical data to anticipate healthcare needs—a methodology with broad interdisciplinary relevance. She has successfully secured major grants, serving as both Principal Investigator and Co-Investigator on nationally and internationally funded research projects.

🌍 Global Impact & Leadership:

Dr. Lee’s influence transcends borders. She has led international collaborations in China, Saudi Arabia, and India, and has designed and implemented transnational nursing degree programs. She is a Visiting Professor at Yangzhou University in China and has advised national healthcare bodies including the UK’s MHRA and Australia’s Nursing and Midwifery Council. Her role as Executive Dean at the Global Banking School involved leading 300+ staff across 10+ campuses and overseeing educational strategies for over 10,000 students. She was instrumental in developing nurse-led clinics in Australia and advising on non-medical prescribing initiatives in Singapore.

🏅 Awards & Recognition:

Dr. Lee has held prestigious appointments, such as serving on editorial boards of top journals including Nurse Education in Practice, BMJ Open, and Journal of Clinical Nursing. She is a Senior Fellow of the Higher Education Academy (SFHEA) and an accredited researcher with the UK Office for National Statistics. In 2024, she was honored as an international judge for the Saudi Government’s health research awards, recognizing her global expertise in patient safety and critical care.

Publications:

  • Cognitive impairment and dementia – Are they linked to childhood health and socioeconomic status? A systematic review

  • ‘Hearing silences’: Exploring culturally safe transitional care: A qualitative study among Turkish-speaking migrant frail older adults

  • Effectiveness of spontaneous pushing versus Valsalva pushing in the second stage of labor on maternal and neonatal outcomes: A systematic review and meta-analysis

  • Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: A qualitative study

  • Diverse Molecular Structures Across The Whole Star-Forming Disk of M83: High fidelity Imaging at 40pc Resolution

  • Severe Loneliness and Isolation in Nursing Students during COVID-19 Lockdown: A Phenomenological Study

  • Trajectory analysis of the work and life experience of healthcare workers during the COVID-19 pandemic: A longitudinal qualitative study

  • Predictors of long-term survival in 5,680 patients admitted to a UK major trauma centre with thoracic injuries

  • Experiences of domestic violence prevention interventions and gender equality promotion work: A qualitative study of Nirdhar Groups in rural India

  • Anxiety and sleep quality among front-line nurses treating first wave COVID-19 in China: The mediating role of mindfulness

Mr.Mulat Erkihun | Immunology and Microbiology | Best Scholar Award

Published on by Phenomenological Research Awards

Mr.  Mulat Erkihun | Immunology and Microbiology | Best Scholar Award

lecturer at Debre Tabor University, Ethiopia.

Mulat Erkihun Agaje is a distinguished Ethiopian medical microbiologist, educator, and clinical researcher with a strong commitment to combating infectious diseases and antimicrobial resistance. With a dual role as a lecturer at Debre Tabor University and a clinical microbiologist at Debre Tabor Comprehensive Specialized Hospital, he bridges academic research with real-world healthcare solutions. His career reflects a passion for medical science, community impact, and advancing diagnostic microbiology.

Profile:

🎓 Education:

Mulat holds a Master of Science in Medical Microbiology (2019) from Bahir Dar University, where he graduated with Very Great Distinction. His M.Sc. coursework focused on advanced virology, bacteriology, immunology, microbial genetics, and hospital infection control. His thesis investigated the antimicrobial resistance profile of Helicobacter pylori in patients with gastric diseases. He also earned a Bachelor of Science in Medical Laboratory Science (2016) from Haramaya University, again graduating with Very Great Distinction. Both programs were conducted in English and included research components.

Professional Experience:

With over eight years of clinical and academic experience, Mulat began his journey as a medical laboratory technologist and then a clinical microbiologist at Felege Hiwot Comprehensive Specialized Hospital. Since 2022, he has served as a lecturer and researcher at Debre Tabor University, where he teaches medical students, supervises research, develops curricula, and provides microbiological services in the affiliated hospital. He has also led quality assurance, community outreach, and strategic laboratory improvements using Lean and Six Sigma approaches.

Research Interests:

Mulat’s research spans a broad spectrum of medical microbiology. His core interests include pathogenesis of infectious diseases, molecular diagnostics, antimicrobial resistance mechanisms, microbial genetics, and the use of nanomaterials in medical applications. He also explores biofilm formation, quorum sensing, vaccine development, and molecular etiology of diseases using PCR and microarray technologies. His multidisciplinary focus contributes to both fundamental science and clinical application.

Awards & Recognition:

Mulat is a recipient of multiple Best Researcher Awards from reputable international platforms in the fields of nanobiotechnology, immunology, and medical microbiology. These awards recognize his outstanding contribution to science, impactful publications, and innovative research on infectious disease management and antimicrobial resistance.

Editorial Activities:

Mulat is an active peer reviewer for leading journals including PLoS ONE, Scientific Reports, and Heliyon. His expertise is sought for evaluating manuscripts on infectious diseases, tuberculosis, and bacterial pathogenesis. His reviewing role showcases his standing in the global microbiological research community.

Professional Memberships:

He is a proud member of the American Society for Microbiology (ASM), Ethiopian Medical Laboratory Association, Health Professionals Association, and Ethiopian Teachers Association. These affiliations support his commitment to continuous learning and global collaboration.

Publications:

  • Erkihun, M., Asmare, Z., Endalamaw, K., Getie, B., Kiros, T., & Berhan, A. (2024). Medical scope of biofilm and quorum sensing during biofilm formation: Systematic review. Bacteria, 3(3), 118–135.
    [Cited by: 19]

  • Asmare, Z., & Erkihun, M. (2023). Recent application of DNA microarray techniques to diagnose infectious disease. Pathology and Laboratory Medicine International, 77–82.
    [Cited by: 10]

  • Erkihun, M., Ayele, B., Asmare, Z., & Endalamaw, K. (2024). Current Updates on Variants of SARS‐CoV‐2: Systematic Review. Health Science Reports, 7(11), e70166.
    [Cited by: 9]

  • Asmare, Z., Erkihun, M., Abebe, W., Ashagre, A., Misganaw, T., & Feleke, S. F. (2024). Catheter-associated urinary tract infections in Africa: Systematic review and meta-analysis. Infection, Disease & Health, 29(3), 172–179.
    [Cited by: 9]

  • Berhan, A., Almaw, A., Solomon, Y., Legese, B., Damtie, S., Erkihun, M., et al. (2023). Tuberculosis treatment outcome and associated factors among tuberculosis patients linked to tuberculosis treatment clinics in Ethiopia, 2023: A multi-center retrospective study. Infection and Drug Resistance, 3367–3378.
    [Cited by: 9]

  • Asmare, Z., Erkihun, M., Abebe, W., & Tamrat, E. (2024). Antimicrobial resistance and ESBL production in uropathogenic Escherichia coli: A systematic review and meta-analysis in Ethiopia. JAC-Antimicrobial Resistance, 6(3), dlae068.
    [Cited by: 5]

  • Kiros, T., Erkihun, M., Wondmagegn, M., Almaw, A., Assefa, A., Berhan, A., et al. (2025). Assessment of Knowledge, Attitude, and Associated Factors of Mpox Among Healthcare Professionals at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia, 2024: A cross-sectional study. Health Science Reports, 8(1), e70371.
    [Cited by: 3]

  • Berhan, A., Damtie, S., Almaw, A., Legese, B., Sharew, B., Getie, B., Erkihun, M., et al. (2024). The role of extracorporeal photopheresis in the management of graft versus host disease: Narrative review. ImmunoTargets and Therapy, 235–246.
    [Cited by: 3]

  • Endalamaw, K., Tadesse, S., Asmare, Z., Kebede, D., Erkihun, M., & Abera, B. (2024). Antimicrobial resistance profile of bacteria from hospital wastewater at two specialized hospitals in Bahir Dar city, Ethiopia. BMC Microbiology, 24(1), 525.
    [Cited by: 3]

  • Erkihun, M., Chanie, D. N., & Siraj, Y. A. (2023). Antimicrobial‐Resistance Profile of Helicobacter pylori, Obtained from Endoscopic Patients in Bahir Dar, North West Ethiopia. Canadian Journal of Infectious Diseases and Medical Microbiology, 2023, Article ID 3615843.
    [Cited by: 3]

Dr.NABIL HASASNA | Hematomolecular pathologist | Future Science Leader Award

Published on by Phenomenological Research Awards

Dr.NABIL HASASNA | Hematomolecular pathologist | Future Science Leader Award

FELLOW at King Hussein Cancer Center, Jordan.

Dr. Nabil M. S. Hasasna is a dedicated and highly trained pathologist specializing in molecular and hemato-pathology. With over a decade of progressive experience across clinical pediatrics and diagnostic pathology, he is currently serving as a Fellow in Molecular Pathology at the esteemed King Hussein Cancer Center in Amman, Jordan. Known for his cross-disciplinary approach, Dr. Hasasna blends advanced diagnostic acumen with compassionate patient care, making him a valuable asset in the modern healthcare landscape.

Profile:

🎓 Educational Background:

Dr. Hasasna holds a Bachelor of Medicine and Bachelor of Surgery (MBBS) from Dow University of Health Sciences, Karachi, where he graduated with honors. He has earned prestigious certifications including the Diplomateship of the Royal College of Pathologists (UK) and the Arab Board in Anatomic Pathology. He also completed foundational stages in both the Arab and Palestinian Boards of Pediatrics, showcasing his diverse medical training.

Professional Experience:

Dr. Hasasna’s medical journey spans multiple disciplines. He served as a Pediatric Resident in various hospitals under the Palestine Ministry of Health, gaining hands-on experience in NICU, pediatric emergency, and hemato-oncology. Later, he advanced his expertise in pathology through a rigorous residency and fellowships at King Hussein Cancer Center, where he now contributes to cutting-edge diagnostic services in molecular and hemato-pathology.

Research Intrest:

Dr. Hasasna’s primary strengths lie in clinical diagnostics and laboratory medicine, he is currently focused on molecular-level cancer diagnostics, an area rapidly evolving with personalized medicine. His fellowships in Molecular-Pathology and Hemato-Pathology offer a platform for future research initiatives, particularly in genetic profiling and targeted therapies.

Honors and Recognitions:

Dr. Nabil M. S. Hasasna has earned notable recognition for his dedication to pathology and clinical excellence. He was awarded the Diplomateship of the Royal College of Pathologists (UK) in 2021, a prestigious certification that marks international distinction in diagnostic pathology. In the same year, he completed the Arab Board in Anatomic Pathology, a rigorous credential reflecting regional expertise in tissue-based diagnostics. His continuous academic advancement, including board qualifications in both surgical pathology and pediatrics, highlights his commitment to interdisciplinary excellence. Dr. Hasasna has contributed to impactful research, with publications cited internationally, and his work has gained visibility in respected journals such as the Journal of International Medical Research and Cancers. His professional affiliations with institutions like the King Hussein Cancer Center, known for high-level cancer diagnostics and research, further validate his reputation as a rising figure in molecular and hemato-pathology. These honors collectively reflect his growing influence in the medical and research community.

Publications:

🔹 APA Format:

Hasasna, N. M. S., [Other authors]. (2025). The role of [18F]FDG PET and clinicopathologic factors in detecting and predicting bone marrow involvement in non-Hodgkin lymphoma. Cancers.

🔹 MLA Format:

Hasasna, Nabil M. S., et al. “The Role of [18F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma.” Cancers, 2025.

🔹 Chicago Style:

Hasasna, Nabil M. S., et al. 2025. “The Role of [18F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma.” Cancers.

🔹 Vancouver Style:

Hasasna NMS, [Other authors]. The role of [18F]FDG PET and clinicopathologic factors in detecting and predicting bone marrow involvement in non-Hodgkin lymphoma. Cancers. 2025.

Ivan Hancco Zirena | Medicine and Dentistry | Lifetime achievement Award

Published on by Phenomenological Research Awards

Prof.Dr.Ivan Hancco Zirena | Medicine and Dentistry | Lifetime achievement Award

post doc at Harvard Medical School, Peru.

Dr. Ivan Hancco Zirena is a distinguished Peruvian physician and researcher specializing in clinical hematology, physiology, and high-altitude medicine. With a rich academic and clinical background spanning multiple continents, Dr. Hancco has carved a niche in understanding human adaptation to hypoxia and extreme environments. Currently serving as a postdoctoral researcher at the Thrombosis and Hemostasis Unit at Harvard Medical School’s Beth Israel Deaconess Medical Center, he contributes to groundbreaking studies on coagulation, red cell physiology, and novel antithrombotic agents.

Profile:

🎓 Educational Background:

Dr. Hancco earned his M.D. from the Universidad Nacional del Altiplano in Puno, Peru (2003), and later specialized in Hematology at Universidad Ricardo Palma, Lima. He pursued advanced studies in France, completing a Master’s in Integrated Biology and Physiology at Université Claude Bernard Lyon 1, followed by a Ph.D. in Physiology at Université Grenoble Alpes. His doctoral thesis investigated hematological responses in high-altitude populations living above 5,000 meters, under the supervision of Dr. Samuel Verges. He is currently completing a postdoctoral fellowship at Harvard Medical School (2023–2025).

💼 Professional Experience:

Dr. Hancco brings extensive experience in both clinical and academic medicine. He has worked in emergency care, hematology units, and cardiovascular rehabilitation in Peru, France, and Spain. His research roles at Laboratoire HP2 (France) and currently at Harvard Medical School (USA) have sharpened his focus on high-impact clinical studies. Additionally, he has provided care to patients with benign and malignant hematologic diseases in military and public hospitals.

Research Interests:

Dr. Hancco’s primary research explores the physiological and hematological adaptations to hypoxia, chronic mountain sickness, erythrocytosis, and cardiovascular and thrombotic responses at high altitudes. His recent work delves into the role of thiol isomerases in hemostasis and thrombosis, with applications in vascular medicine and novel antithrombotic therapies. His interdisciplinary approach bridges physiology, hematology, environmental medicine, and cellular biology.

Teaching Experience:

A passionate educator, Dr. Hancco has taught hematology, physiology, and molecular biology at top Peruvian universities including Universidad de San Martín de Porres, Universidad Científica del Sur, and Universidad Nacional del Altiplano. He has led student research groups, facilitated international exchange programs, and integrated research into medical training. His teaching style fosters critical thinking, debate, and hands-on learning in laboratory and clinical environments.

Skills:

Dr. Hancco is skilled in a wide array of biomedical techniques including flow cytometry, cell culture, platelet aggregation, protein purification, magnetic cell levitation, cytokinesis analysis, microscopy, and complete blood count analysis. These tools have supported his innovative research in hypoxia and hemostasis.

🏅 Recognition and Impact:

Dr. Hancco’s research on chronic mountain sickness and thrombosis has global relevance, particularly for populations living in extreme altitudes. His findings contribute to improved diagnostic and therapeutic strategies for hematological disorders in both high- and low-altitude settings. His work has earned him collaboration with world-renowned institutions and recognition as a rising figure in global hematology and physiology.

Publications:

  • Galloylated polyphenols represent a new class of antithrombotic agents with broad activity against thiol isomerases.
    Journal of Thrombosis and Haemostasis, 2025.

  • Cerebral blood flow in Andean children and adolescents living above 5,000 m.
    Journal of Neurophysiology, 2025.

  • Neurological manifestations associated with exercise at altitude.
    Current Neurology and Neuroscience Reports, 2025.

  • Pain perception threshold in young high-altitude natives after acute exposure to severe hypoxic conditions.
    Oxygen (Basel), 2025.

  • Micro- and macrovascular function in the highest city in the world: A cross-sectional study.
    Lancet Regional Health – Americas, 2024.

  • Performance in the six-minute walking test does not discriminate excessive erythrocytosis patients in a severe hypoxic environment.
    International Journal of Environmental Research and Public Health, 2024.

  • Expedition 5300: Limits of human adaptations in the highest city in the world.
    Journal of Physiology, 2024.

  • Cerebral homeostasis and orthostatic responses in residents of the highest city in the world.
    Scientific Reports, 2024.

  • Lower glycemia levels in subjects with excessive erythrocytosis during the oral glucose tolerance test living in conditions of severe hypoxia.
    Frontiers in Physiology, 2024.

  • Are coagulation profiles in Andean highlanders with excessive erythrocytosis favouring hypercoagulability?
    Experimental Physiology, 2024.